
Chimeric antigen receptor T cell (CAR-T) therapy has gained much traction and attention in the past years for its innovative …

The overall cancer mortality rate in the US fell by 2.2% from 2016 to 2017, the largest ever annual decline …

The multiple sclerosis (MS) drug teriflunomide boosts the effectiveness of cancer drugs in treating glioblastoma, according to researchers from UC, …

Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival, …

Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …

Research emerging from the University of Leeds and The Institute of Cancer research has revealed that a virus, known as …

Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of …
There has been positive news coming from researchers at the Huntsman Cancer Institute, at the University of Utah, reporting on …

ImmunoCellular Therapeutics has been awarded a $19.9 million grant by California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, …

The New York Genome Center and IBM Watson have joined forces to accelerate a new era of genomic medicine, initially …

A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain …
Merck KGaA has completed patient enrollment for a phase III global trial of its first-in-class integrin inhibitor in a rare …
Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …
Nearly a quarter of all cancer diagnoses in England came after a patient had been admitted to hospital for emergency …